Skip to main content

Table 2 Clinicopathological features between two groups of KRT6B

From: Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment

Covariates

High KRT6B

Low KRT6B

P value

No. (%)

No. (%)

Age (years)

0.9484

 < 65

74 (36.82%)

76 (37.62%)

 

 ≥ 65

127 (63.18%)

126 (62.38%)

 

Gender

0.0382

 Female

62 (30.85%)

43 (21.29%)

 

 Male

139 (69.15%)

159 (78.71%)

 

Status

0.0031

 Alive

103 (51.24%)

73 (36.14%)

 

 Dead

98 (48.76%)

129 (63.86%)

 

Grade

0.0027

 High

198 (98.51%)

182 (90.1%)

 

 Low

3 (1.49%)

17 (8.42%)

 

 Unknown

0 (0%)

3 (1.49%)

 

T classification

0.3839

 T0

0 (0%)

1 (0.5%)

 

 T1

0 (0%)

3 (1.49%)

 

 T2

57 (28.36%)

60 (29.7%)

 

 T3

98 (48.76%)

94 (46.53%)

 

 T4

29 (14.43%)

28 (13.86%)

 

 Unknown

17 (8.46%)

16 (7.92%)

 

N classification

0.0099

 N0

124 (61.69%)

111 (54.95%)

 

 N1

27 (13.43%)

17 (8.42%)

 

 N2

28 (13.93%)

47 (23.27%)

 

 N3

1 (0.5%)

6 (2.97%)

 

 Unknown

21 (10.45%)

21 (10.4%)

 

M classification

1

 M0

95 (47.26%)

100 (49.5%)

 

 M1

5 (2.49%)

6 (2.97%)

 

 Unknown

101 (50.25%)

96 (47.52%)

 

TNM stage

0.3435

 I

0 (0%)

2 (0.99%)

 

 II

64 (31.84%)

64 (31.68%)

 

 III

75 (37.31%)

65 (32.18%)

 

 IV

61 (30.35%)

70 (34.65%)

 

 Unknown

1 (0.5%)

1 (0.5%)

Â